[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 799,793
  • Shares Outstanding, K 155,905
  • Annual Sales, $ 2,800 K
  • Annual Income, $ -115,180 K
  • EBIT $ -117 M
  • EBITDA $ -105 M
  • 60-Month Beta 2.36
  • Price/Sales 308.47
  • Price/Cash Flow N/A
  • Price/Book 5.01

Options Overview Details

View History
  • Implied Volatility 88.28% (-4.67%)
  • Historical Volatility 95.67%
  • IV Percentile 11%
  • IV Rank 8.61%
  • IV High 254.89% on 03/24/26
  • IV Low 72.59% on 12/24/25
  • Expected Move (DTE 31) 0.85 (17.17%)
  • Put/Call Vol Ratio 0.63
  • Today's Volume 753
  • Volume Avg (30-Day) 4,265
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 51,063
  • Open Int (30-Day) 66,079
  • Expected Range 4.10 to 5.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.20
  • Number of Estimates 3
  • High Estimate $-0.17
  • Low Estimate $-0.21
  • Prior Year $-0.24
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.43 +44.42%
on 04/20/26
6.72 -26.34%
on 05/11/26
+1.37 (+38.27%)
since 04/17/26
3-Month
2.24 +120.98%
on 03/12/26
6.72 -26.34%
on 05/11/26
+2.25 (+83.33%)
since 02/18/26
52-Week
2.24 +120.98%
on 03/12/26
6.72 -26.34%
on 05/11/26
+2.07 (+71.87%)
since 05/16/25

Most Recent Stories

More News
Absci Q1 Earnings Call Highlights

Absci (NASDAQ:ABSI) executives on Wednesday outlined a “data-rich” 2026 anchored by multiple clinical updates for ABS-201, the company’s anti-prolactin receptor antibody being studied in androgenetic...

ABSI : 4.95 (-3.51%)
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling...

ABSI : 4.95 (-3.51%)
Absci Reports Tomorrow With Investors Still Waiting for the AI Drug Platform to Prove Itself

Barchart Research What to Expect from ABSI Earnings ABSI Generated May 6, 2026 Current Price $5.95 EPS Estimate $$-0.19 Consensus Rating Strong Buy Average Move 7.52% Absci Reports Tomorrow With Investors...

ABSI : 4.95 (-3.51%)
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative...

ABSI : 4.95 (-3.51%)
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative...

ABSI : 4.95 (-3.51%)
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative...

ABSI : 4.95 (-3.51%)
Absci Reports Earnings Today: Can Biotech Upstart Prove Skeptics Wrong?

ABSI : 4.95 (-3.51%)
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Unveiled human ex vivo data demonstrating that ABS-201...

ABSI : 4.95 (-3.51%)
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic

VANCOUVER, Wash. and NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative...

ABSI : 4.95 (-3.51%)
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative...

ABSI : 4.95 (-3.51%)

Business Summary

Absci Corporation is a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design. Absci Corporation is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 5.60
2nd Resistance Point 5.43
1st Resistance Point 5.19
Last Price 4.95
1st Support Level 4.78
2nd Support Level 4.61
3rd Support Level 4.37

See More

52-Week High 6.72
Fibonacci 61.8% 5.01
Last Price 4.95
Fibonacci 50% 4.48
Fibonacci 38.2% 3.95
52-Week Low 2.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.